BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinicalstage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in a fireside chat at the Jefferies Global Healthcare Conference taking place in New York City, NY June 5 – 6, 2024. Fireside Chat details Date: Wednesday, June 5, 2024 Time: 1:00 – 1:25 PM ET Webcast Link: https://wsw.com/jefferiesw ...

BOSTON, May 28, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinicalstage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that its Board of Directors has appointed Thomas Schuetz, M.D., Ph.D., President of Research and Development and Vice Chair of the Board of Directors of the Company, as President and Chief Executive Officer of the Company, effective May 28, 2024. Vered Bisker-Leib, P ...

Investors with an interest in Retail - Restaurants stocks have likely encountered both Compass Group PLC (CMPGY) and Chipotle Mexican Grill (CMG) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on earnin ...

eskymaks/iStock via Getty Images Listen here or on the go via Apple Podcasts and Spotify Analyst Alex Carchidi discusses positive news coming out of psychedelic space (1:00). Recent earnings show companies moving closer to commercialization (3:35). Cybin and Atai developments; clinical studies and regulatory relief (5:25). Why now is the time to get into the space; ranking Compass and MindMed above the rest (8:00). Proper metrics and diversified pipelines (10:20). Transcript Rena Sherbill: Alex Carchidi, al ...

NEW YORK, May 23, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Compass Minerals International, Inc. ("Compass Minerals" or the "Company") (NYSE: CMP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Compass Minerals investors who were adversely affected by alleged securities fraud between November 29, 2023 and March 22, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslr ...

Psychedelic medicines are rapidly gaining legitimacy on several fronts. As a psychedelic therapy developer, Compass Pathways (CMPS 1.02%) is on the cutting edge of innovation in treating mood disorders. That makes it an exciting, if quite risky, investment. External developments could have big implications The second catalyst is a bit different in nature. Compass isn't the only biotech working on developing psychedelic medicines. Lykos Therapeutics is a for-profit public benefit corporation (PBC) that aims ...

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fid ...

Financial Data and Key Metrics Changes - Operating profit increased by 19% to $1.5 billion, driven by organic revenue growth of 11% and an operating margin of 7.1% [1][8] - EPS rose by 16%, and dividends grew by the same percentage, reflecting a strong cash position [9] - CapEx normalized to 3.3% of revenue, with expectations to reach around 3.5% for the full year [10][9] Business Line Data and Key Metrics Changes - Revenue growth components included pricing at around 5%, net new at 3.7%, and volume growth of approximately 2.5% [5][6] - Volume growth was driven by a return to office and increased events, particularly in B&I and Sports & Leisure [6][48] - The company expects volume growth to moderate in the second half as comparatives become tougher [7] Market Data and Key Metrics Changes - The company estimates its addressable market to be around $300 billion, with a global market share of less than 15% [15][16] - The vending market in the U.S. is estimated at $25 billion, with the company holding a 12% market share, indicating significant growth potential [18] Company Strategy and Development Direction - The company focuses on core markets and sectors, investing in in-fill M&A to unlock future growth sources [15][4] - The strategy includes exiting non-core countries and refining the portfolio to enhance focus on markets with better growth prospects [11][12] - The company aims to deepen its presence in larger, more developed markets, which offer better growth opportunities [11][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a full-year underlying profit growth guidance of around 15% [14] - The company is optimistic about improving retention rates and new business wins, with a strong pipeline for future growth [34][43] - Management acknowledged challenges such as labor shortages and sticky inflation but emphasized ongoing improvements in labor turnover rates [78][79] Other Important Information - The company has exited four non-core countries and plans to exit Brazil, focusing resources on markets with greater potential [11][59] - M&A activities are expected to be accretive to EBIT and growth moving forward, with a disciplined approach to capital deployment [25][62] Q&A Session Summary Question: On net contract sales contribution and retention rates - Management confirmed that the 3.7% net new is slightly ahead of guidance and expects retention rates to improve in the second half [33][34] Question: On M&A and share buybacks - Management indicated that M&A opportunities will dictate the timing of share buybacks, maintaining a conservative leverage ratio [37] Question: On volume growth expectations - Management acknowledged that volume growth is expected to moderate but emphasized the potential for sustained growth through improved digital offerings [39][48] Question: On Brazil's exit and market opportunities - Management explained that Brazil was deemed unattractive due to limited opportunities in key sectors, leading to the decision to exit [58][59] Question: On inflation and guidance - Management noted that inflation rates are in line with pricing, and the guidance for operating profit growth is driven by underlying trading [67][70] Question: On first-time outsourcing and labor shortages - Management confirmed that they are in line with market peers regarding first-time outsourcing and are managing labor shortages effectively [72][78]

Investors with an interest in Retail - Restaurants stocks have likely encountered both Compass Group PLC (CMPGY) and Shake Shack (SHAK) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earni ...

Compass Group PLC (OTCPK:CMPGF) Q1 2024 Earnings Conference Call February 8, 2024 3:00 AM ET Company Participants Dominic Blakemore - Group Chief Executive Officer Petros Parras - Group Chief Financial Officer Conference Call Participants Jamie Rollo - Morgan Stanley Vicki Stern - Barclays Jaafar Mestari - BNP Paribas Julien Richer - Kepler Jarrod Castle - UBS Neil Tyler - Redburn Atlantic Dominic Blakemore Thank you. Good morning everyone and welcome to the first quarter results call. I'm delighted to have ...